---
schema_version: "secwatch.filing_event.v1"
accession: "0000818479-24-000076"
form_type: "8-K"
ticker: "XRAY"
cik: "0000818479"
company_name: "DENTSPLY SIRONA Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:47:01.476569+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Dentsply Sirona suspends Byte aligner sales after FDA consult; Q3 rev ~$951M, impairment up to $550M

## Summary
- Voluntarily suspends sale/marketing of Byte aligners and impression kits in consultation with FDA.
- Byte represents ~5% of annual revenue; suspension expected to materially impact operations.
- Prelim Q3 net sales ~$951M; adjusted EPS guided $0.49-$0.51 (non-GAAP).
- Expects $450-$550M non-cash goodwill impairment (net of tax) for Orthodontic Aligner and Implant reporting units.
- Q3 sales benefited by ~$20M shift of distributor orders from Q4 due to ERP implementation.

## SEC filing metadata
- accession: 0000818479-24-000076
- form_type: 8-K
- ticker: XRAY
- cik: 0000818479
- company_name: DENTSPLY SIRONA Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/0000818479-24-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/xray-20241024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000818479-24-000076
- JSON: https://secwatch.observer/filing/0000818479-24-000076.json
- Plain text: https://secwatch.observer/filing/0000818479-24-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.